Is Viatris Stock A Buy?
If you've ever breathed a sigh of relief at the pharmacy register because your generic medication was cheaper than the brand-name version, you've experienced the economic power of pharmaceutical manufacturers. By undercutting the branded competition, big manufacturers save you money -- while getting rich in the process.
That's why Viatris (NASDAQ: VTRS) is a stock that might be right for your portfolio, especially if you're looking for a long-term and slow-burn investment that's currently selling at a bargain. On the other hand, the company still has a lot to prove, as it's been around for less than a year. Is Viatris about to be a rising star in healthcare, or will it struggle to win against entrenched competition?
Image source: Getty Images.
Source Fool.com
